These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34544186)

  • 21. Antimicrobial management of sepsis and septic shock.
    Sharma S; Kumar A
    Clin Chest Med; 2008 Dec; 29(4):677-87, ix. PubMed ID: 18954702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program.
    Ferrer R; Martin-Loeches I; Phillips G; Osborn TM; Townsend S; Dellinger RP; Artigas A; Schorr C; Levy MM
    Crit Care Med; 2014 Aug; 42(8):1749-55. PubMed ID: 24717459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing antimicrobial therapy in sepsis and septic shock.
    Kumar A
    Crit Care Clin; 2009 Oct; 25(4):733-51, viii. PubMed ID: 19892250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rules of anti-infection therapy for sepsis and septic shock.
    Zhou X; Su LX; Zhang JH; Liu DW; Long Y
    Chin Med J (Engl); 2019 Mar; 132(5):589-596. PubMed ID: 30807357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU.
    Garduno A; Martín-Loeches I
    Expert Rev Anti Infect Ther; 2022 Apr; 20(4):513-531. PubMed ID: 34727820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers.
    Salluh JI; Nobre V; Povoa P
    Crit Care; 2014 May; 18(3):142. PubMed ID: 25032999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: A meta-analysis.
    Guo Y; Gao W; Yang H; Ma C; Sui S
    Heart Lung; 2016; 45(5):454-9. PubMed ID: 27340006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship.
    Nauclér P; Huttner A; van Werkhoven CH; Singer M; Tattevin P; Einav S; Tängdén T
    Clin Microbiol Infect; 2021 Feb; 27(2):175-181. PubMed ID: 32120032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.
    Albrich WC; Harbarth S
    Intensive Care Med; 2015 Oct; 41(10):1739-51. PubMed ID: 26194026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock.
    Pop-Vicas A; Opal SM
    Virulence; 2014 Jan; 5(1):206-12. PubMed ID: 24200870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.
    Gomes Silva BN; Andriolo RB; Atallah AN; Salomão R
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007934. PubMed ID: 21154391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing and Spectrum of Antibiotic Treatment for Suspected Sepsis and Septic Shock: Why so Controversial?
    Pak TR; Rhee C; Klompas M
    Infect Dis Clin North Am; 2022 Dec; 36(4):719-733. PubMed ID: 36328632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?
    Pea F; Viale P
    Crit Care; 2009; 13(3):214. PubMed ID: 19519961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis.
    Gutiérrez-Pizarraya A; Leone M; Garnacho-Montero J; Martin C; Martin-Loeches I
    Expert Rev Clin Pharmacol; 2017 Apr; 10(4):457-465. PubMed ID: 28266901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing antimicrobial therapy in sepsis and septic shock.
    Kumar A
    Crit Care Nurs Clin North Am; 2011 Mar; 23(1):79-97. PubMed ID: 21316569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Early and Appropriate Antibiotic Administration Improve Mortality in Emergency Department Patients with Severe Sepsis or Septic Shock?
    Sherwin R; Winters ME; Vilke GM; Wardi G
    J Emerg Med; 2017 Oct; 53(4):588-595. PubMed ID: 28916120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [First-line anti-infective treatment in sepsis].
    Burgmann H
    Med Klin Intensivmed Notfmed; 2014 Nov; 109(8):577-82. PubMed ID: 25344412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed Administration of Antibiotics Beyond the First Hour of Recognition Is Associated with Increased Mortality Rates in Children with Sepsis/Severe Sepsis and Septic Shock.
    Sankar J; Garg M; Ghimire JJ; Sankar MJ; Lodha R; Kabra SK
    J Pediatr; 2021 Jun; 233():183-190.e3. PubMed ID: 33359300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
    Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
    Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.